ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

June 29, 2001

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

October 24, 1986

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data

June 28, 2013

House: NCI Should Coordinate National Cancer Program

August 4, 1995

NCI Considers Making Prevention Trial From NSABP; Other Groups Approached

May 13, 1994